Study to Determine the Clinical Significance of Intravascular OCT-NIRAF
Conditions: Cardiovascular Diseases; Coronary Artery Disease Interventions: Device: OCT-NIRAF Sponsors: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Evaluation of the Patency of Intercostal and Lumbar Arteries Before and After the STABILISE Technique ni Patients With Type Baortic Dissection (SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique)
Conditions: Aortic Dissection; Spinal Cord Ischemia Interventions: Other: STABILISE Sponsors: Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA; Cardiovascular Center of the University of Lisbon; Unidade Local de Sa úde Santa Maria Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique
Conditions: Aortic Dissection; Spinal Cord Ischemia Interventions: Other: STABILISE Sponsors: Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA; Cardiovascular Center of the University of Lisbon; Unidade Local de Sa úde Santa Maria Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support
Conditions: Cardiogenic Shock Sponsors: Universit ät Münster Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Conditions: Ischemia Reperfusion Injury; Peripheral Artery Disease Interventions: Drug: Vitamin B6 25 MG; Drug: Vitamin B6 50 MG; Drug: Vitamin B6 100 MG; Drug: Placebo Sponsors: Milton S. Hershey Medical Center; American Heart Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ipsc biobaNk oF biomarkERs divErsity iN Cardiovascular disEase
Conditions: Cardiovascular Diseases; Arrythmia; Cardiomyopathies; Heart Failure; Cerebrovascular Accident; Congenital Heart Disease; Cardiometabolic Syndrome Sponsors: Lawson Health Research Institute; Greenstone Biosciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Conditions: Epilepsy; Dyslipidemia Interventions: Drug: Atorvastatin 10mg; Other: Modification of dietary fat composition Sponsors: Johns Hopkins University; American Heart Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm
Conditions: Mitral Stenosis Interventions: Drug: Ivabradine; Drug: Beta blocker Sponsors: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The EXPLAIN Study: Exploring Plant-Based Meat Analogues for Their Impact on Health
Conditions: Blood Pressure; Cardiometabolic Health Interventions: Other: Standardized diet with commercially available animal meats (comparator products); Other: Standardized diet with commercially available PBMAs (intervention products) Sponsors: Wageningen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Cardiothoracic Critical Care as Subspecialty and Its Core Competencies
Conditions: Consensus Development Interventions: Other: Delphi Questionnaire Sponsors: Ohio State University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
Conditions: Oxidative Injury; Stress Physiological; Discogenic Pain; Cardiovascular Risk Factor; Space Maintenance; Epigenetic Changes; LONGEVITY 1; Neuroplasticity; NGS Interventions: Other: Biological sample collection Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico; University of Milan; Italian Air Force; A-Tono; Ministry of Defense, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Estrogen Deficiency on Cardiovascular Risk
Conditions: Postmenopausal Symptoms; Cardiovascular Diseases Interventions: Drug: Placebo; Drug: Estradiol Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Phase 2 Study of JK07 in Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction; Heart Failure With Preserved Ejection Fraction Interventions: Drug: JK07; Drug: Placebo Sponsors: Salubris Biotherapeutics Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
School Readiness Intervention for Preschool Children With Sickle Cell Disease
Conditions: Sickle Cell Disease Interventions: Device: The adapted Kids in Transition to School Intervention; Device: Standard school resources Sponsors: St. Jude Children ' s Research Hospital; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy
Conditions: Obstructive Hypertrophic Cardiomyopathy Interventions: Device: DragonFire Transcatheter Myocardial Radiofrequency Ablation System Sponsors: Hangzhou Valgen Medtech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
